Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1984-09

AUTHORS

J. W. Ward, A. McBurney, P. R. Farrow, P. Sharp

ABSTRACT

Preliminary investigation in 3 healthy volunteers suggested that intravenous pinacidil in a dose of 0.2 mg/kg had a potent but well-tolerated hypotensive action in the supine position. Facial flushing, uncomfortable chest sensation and distressing postural hypotension occurred at serum concentrations above 300 ng/ml. Pinacidil, 0.2 mg/kg, was given intravenously over 4 min to 15 healthy volunteers in the supine position. Maximum fall in mean arterial pressure (MAP) was 15.7±6.0 mmHg. Maximum rise in heart rate was 23.8±6.6 beats/min. Pinacidil serum distribution half-life (\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document} $${\text{T}}_{{\raise0.7ex\hbox{${\text{1}}$} \!\mathord{\left/ {\vphantom {{\text{1}} {{\text{2}}\alpha }}}\right.\kern-\nulldelimiterspace}\!\lower0.7ex\hbox{${{\text{2}}\alpha }$}}}$$ \end{document}) was 13.4±8.5 min and elimination half-life (\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document} $${\text{T}}_{{\raise0.7ex\hbox{${\text{1}}$} \!\mathord{\left/ {\vphantom {{\text{1}} {{\text{2}}\beta }}}\right.\kern-\nulldelimiterspace}\!\lower0.7ex\hbox{${{\text{2}}\beta }$}}}$$ \end{document}) was 2.13±0.49 h. The apparent volume of distribution (Vdβ) was 90.3±13.21 and total body clearance was 31.1±9.61/h. Pinacidil was approximately 40% bound to plasma protein over the concentration range 40–400 ng/ml. Urinary excretion of unchanged pinacidil accounted for 5.7 ± 1.3% of the administered dose over 24 hours and urinary excretion of the major metabolite, pinacidil pyridine-N-oxide, was 31.6±9.2% of the administered dose. It was concluded that intravenous pinacidil is a potent vasodilator hypotensive compound, with a duration of action between 1.5 and 2 h. More... »

PAGES

603-608

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00543493

DOI

http://dx.doi.org/10.1007/bf00543493

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1043833646

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/6468476


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Guanidines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kinetics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pinacidil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Posture", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vasodilator Agents", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology Groby Road Hospital Leicester, England", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Clinical Pharmacology Groby Road Hospital Leicester, England"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ward", 
        "givenName": "J. W.", 
        "id": "sg:person.0675422255.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675422255.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology Groby Road Hospital Leicester, England", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Clinical Pharmacology Groby Road Hospital Leicester, England"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McBurney", 
        "givenName": "A.", 
        "id": "sg:person.0743535455.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743535455.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology Groby Road Hospital Leicester, England", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Clinical Pharmacology Groby Road Hospital Leicester, England"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Farrow", 
        "givenName": "P. R.", 
        "id": "sg:person.01011650655.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01011650655.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology Groby Road Hospital Leicester, England", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Clinical Pharmacology Groby Road Hospital Leicester, England"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sharp", 
        "givenName": "P.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/clpt.1980.234", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033747726", 
          "https://doi.org/10.1038/clpt.1980.234"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00562058", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036861154", 
          "https://doi.org/10.1007/bf00562058"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01975139", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036141189", 
          "https://doi.org/10.1007/bf01975139"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/clpt.1981.40", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048755408", 
          "https://doi.org/10.1038/clpt.1981.40"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1984-09", 
    "datePublishedReg": "1984-09-01", 
    "description": "Preliminary investigation in 3 healthy volunteers suggested that intravenous pinacidil in a dose of 0.2 mg/kg had a potent but well-tolerated hypotensive action in the supine position. Facial flushing, uncomfortable chest sensation and distressing postural hypotension occurred at serum concentrations above 300 ng/ml. Pinacidil, 0.2 mg/kg, was given intravenously over 4 min to 15 healthy volunteers in the supine position. Maximum fall in mean arterial pressure (MAP) was 15.7\u00b16.0 mmHg. Maximum rise in heart rate was 23.8\u00b16.6 beats/min. Pinacidil serum distribution half-life (\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym}\n\t\t\t\t\\usepackage{amsfonts}\n\t\t\t\t\\usepackage{amssymb}\n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}\n$${\\text{T}}_{{\\raise0.7ex\\hbox{${\\text{1}}$} \\!\\mathord{\\left/ {\\vphantom {{\\text{1}} {{\\text{2}}\\alpha }}}\\right.\\kern-\\nulldelimiterspace}\\!\\lower0.7ex\\hbox{${{\\text{2}}\\alpha }$}}}$$\n\\end{document}) was 13.4\u00b18.5 min and elimination half-life (\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym}\n\t\t\t\t\\usepackage{amsfonts}\n\t\t\t\t\\usepackage{amssymb}\n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}\n$${\\text{T}}_{{\\raise0.7ex\\hbox{${\\text{1}}$} \\!\\mathord{\\left/ {\\vphantom {{\\text{1}} {{\\text{2}}\\beta }}}\\right.\\kern-\\nulldelimiterspace}\\!\\lower0.7ex\\hbox{${{\\text{2}}\\beta }$}}}$$\n\\end{document}) was 2.13\u00b10.49 h. The apparent volume of distribution (Vd\u03b2) was 90.3\u00b113.21 and total body clearance was 31.1\u00b19.61/h. Pinacidil was approximately 40% bound to plasma protein over the concentration range 40\u2013400 ng/ml. Urinary excretion of unchanged pinacidil accounted for 5.7 \u00b1 1.3% of the administered dose over 24 hours and urinary excretion of the major metabolite, pinacidil pyridine-N-oxide, was 31.6\u00b19.2% of the administered dose. It was concluded that intravenous pinacidil is a potent vasodilator hypotensive compound, with a duration of action between 1.5 and 2 h.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf00543493", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054337", 
        "issn": [
          "0031-6970", 
          "1432-1041"
        ], 
        "name": "European Journal of Clinical Pharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "26"
      }
    ], 
    "keywords": [
      "mean arterial pressure", 
      "healthy volunteers", 
      "urinary excretion", 
      "supine position", 
      "pinacidil pyridine-N-oxide", 
      "new potent vasodilator", 
      "total body clearance", 
      "beats/min", 
      "duration of action", 
      "chest sensations", 
      "postural hypotension", 
      "hypotensive action", 
      "arterial pressure", 
      "hypotensive effect", 
      "serum concentrations", 
      "body clearance", 
      "potent vasodilator", 
      "heart rate", 
      "maximum fall", 
      "pinacidil", 
      "apparent volume", 
      "serum distribution", 
      "hypotensive compounds", 
      "major metabolite", 
      "dose", 
      "volunteers", 
      "excretion", 
      "min", 
      "maximum rise", 
      "hypotension", 
      "vasodilators", 
      "mmHg", 
      "pharmacokinetics", 
      "clearance", 
      "sensation", 
      "duration", 
      "action", 
      "hours", 
      "metabolites", 
      "concentration", 
      "fall", 
      "preliminary investigation", 
      "protein", 
      "elimination", 
      "rate", 
      "effect", 
      "volume", 
      "pressure", 
      "investigation", 
      "rise", 
      "compounds", 
      "position", 
      "distribution", 
      "pyridine N-oxide"
    ], 
    "name": "Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator", 
    "pagination": "603-608", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1043833646"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00543493"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "6468476"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00543493", 
      "https://app.dimensions.ai/details/publication/pub.1043833646"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_175.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf00543493"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00543493'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00543493'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00543493'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00543493'


 

This table displays all metadata directly associated to this object as RDF triples.

195 TRIPLES      21 PREDICATES      95 URIs      83 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00543493 schema:about N548f4da7d2d041f299c1c1f975b01b1d
2 N59066f1a88144e66947fd3d26f8d1b5d
3 N694b139b213340e0a8ab62d7cef78e29
4 N720ba219dbee46d2a91786e5ea0e5988
5 N86c4c1acd90c44ac9d2675d5daf2c85f
6 Na1a40b982602460a907b868a8752d113
7 Nb848d5af93634431ab51b9cdfbd62342
8 Nd52d9e3851f44c6c83ec73bf80f1c574
9 Nd8d3ba159ebc48dc9a3a89ff1397bf92
10 Ndda367c5e49048a5a32eabf5f35267e7
11 Ne8a982d639a44563af3299a0a26225a8
12 anzsrc-for:11
13 anzsrc-for:1103
14 schema:author N7a6e899cd3874c70a631b98bff2a59a0
15 schema:citation sg:pub.10.1007/bf00562058
16 sg:pub.10.1007/bf01975139
17 sg:pub.10.1038/clpt.1980.234
18 sg:pub.10.1038/clpt.1981.40
19 schema:datePublished 1984-09
20 schema:datePublishedReg 1984-09-01
21 schema:description Preliminary investigation in 3 healthy volunteers suggested that intravenous pinacidil in a dose of 0.2 mg/kg had a potent but well-tolerated hypotensive action in the supine position. Facial flushing, uncomfortable chest sensation and distressing postural hypotension occurred at serum concentrations above 300 ng/ml. Pinacidil, 0.2 mg/kg, was given intravenously over 4 min to 15 healthy volunteers in the supine position. Maximum fall in mean arterial pressure (MAP) was 15.7±6.0 mmHg. Maximum rise in heart rate was 23.8±6.6 beats/min. Pinacidil serum distribution half-life (\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document} $${\text{T}}_{{\raise0.7ex\hbox{${\text{1}}$} \!\mathord{\left/ {\vphantom {{\text{1}} {{\text{2}}\alpha }}}\right.\kern-\nulldelimiterspace}\!\lower0.7ex\hbox{${{\text{2}}\alpha }$}}}$$ \end{document}) was 13.4±8.5 min and elimination half-life (\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document} $${\text{T}}_{{\raise0.7ex\hbox{${\text{1}}$} \!\mathord{\left/ {\vphantom {{\text{1}} {{\text{2}}\beta }}}\right.\kern-\nulldelimiterspace}\!\lower0.7ex\hbox{${{\text{2}}\beta }$}}}$$ \end{document}) was 2.13±0.49 h. The apparent volume of distribution (Vdβ) was 90.3±13.21 and total body clearance was 31.1±9.61/h. Pinacidil was approximately 40% bound to plasma protein over the concentration range 40–400 ng/ml. Urinary excretion of unchanged pinacidil accounted for 5.7 ± 1.3% of the administered dose over 24 hours and urinary excretion of the major metabolite, pinacidil pyridine-N-oxide, was 31.6±9.2% of the administered dose. It was concluded that intravenous pinacidil is a potent vasodilator hypotensive compound, with a duration of action between 1.5 and 2 h.
22 schema:genre article
23 schema:isAccessibleForFree false
24 schema:isPartOf N24e515e076c44f689c4465587699eae0
25 N2c57b9e434be424aafafbbddbf5f0fc3
26 sg:journal.1054337
27 schema:keywords action
28 apparent volume
29 arterial pressure
30 beats/min
31 body clearance
32 chest sensations
33 clearance
34 compounds
35 concentration
36 distribution
37 dose
38 duration
39 duration of action
40 effect
41 elimination
42 excretion
43 fall
44 healthy volunteers
45 heart rate
46 hours
47 hypotension
48 hypotensive action
49 hypotensive compounds
50 hypotensive effect
51 investigation
52 major metabolite
53 maximum fall
54 maximum rise
55 mean arterial pressure
56 metabolites
57 min
58 mmHg
59 new potent vasodilator
60 pharmacokinetics
61 pinacidil
62 pinacidil pyridine-N-oxide
63 position
64 postural hypotension
65 potent vasodilator
66 preliminary investigation
67 pressure
68 protein
69 pyridine N-oxide
70 rate
71 rise
72 sensation
73 serum concentrations
74 serum distribution
75 supine position
76 total body clearance
77 urinary excretion
78 vasodilators
79 volume
80 volunteers
81 schema:name Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator
82 schema:pagination 603-608
83 schema:productId N0d21ea4118e44cc783fdf6f82fab558c
84 N485dd27e80994fce93ee0203b7e7c61a
85 Nd3b755d751974086acd37b091e776a66
86 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043833646
87 https://doi.org/10.1007/bf00543493
88 schema:sdDatePublished 2022-12-01T06:18
89 schema:sdLicense https://scigraph.springernature.com/explorer/license/
90 schema:sdPublisher N2355a0a8a9994580a57be4735f2bdaa9
91 schema:url https://doi.org/10.1007/bf00543493
92 sgo:license sg:explorer/license/
93 sgo:sdDataset articles
94 rdf:type schema:ScholarlyArticle
95 N0d21ea4118e44cc783fdf6f82fab558c schema:name pubmed_id
96 schema:value 6468476
97 rdf:type schema:PropertyValue
98 N1c6aa2d48db347beac9dcdf98b294674 rdf:first sg:person.0743535455.00
99 rdf:rest Nd558d92b125644cb8835729de7ac0748
100 N2355a0a8a9994580a57be4735f2bdaa9 schema:name Springer Nature - SN SciGraph project
101 rdf:type schema:Organization
102 N24e515e076c44f689c4465587699eae0 schema:volumeNumber 26
103 rdf:type schema:PublicationVolume
104 N2c57b9e434be424aafafbbddbf5f0fc3 schema:issueNumber 5
105 rdf:type schema:PublicationIssue
106 N485dd27e80994fce93ee0203b7e7c61a schema:name dimensions_id
107 schema:value pub.1043833646
108 rdf:type schema:PropertyValue
109 N548f4da7d2d041f299c1c1f975b01b1d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Adult
111 rdf:type schema:DefinedTerm
112 N59066f1a88144e66947fd3d26f8d1b5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Blood Pressure
114 rdf:type schema:DefinedTerm
115 N694b139b213340e0a8ab62d7cef78e29 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Pinacidil
117 rdf:type schema:DefinedTerm
118 N720ba219dbee46d2a91786e5ea0e5988 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Humans
120 rdf:type schema:DefinedTerm
121 N7a6e899cd3874c70a631b98bff2a59a0 rdf:first sg:person.0675422255.52
122 rdf:rest N1c6aa2d48db347beac9dcdf98b294674
123 N86c4c1acd90c44ac9d2675d5daf2c85f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Vasodilator Agents
125 rdf:type schema:DefinedTerm
126 Na1a40b982602460a907b868a8752d113 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Guanidines
128 rdf:type schema:DefinedTerm
129 Nacdfdffc58c441e6a5852af8c2700274 rdf:first Nf6b573fa3f4545fa89a31f51a6b7ec6a
130 rdf:rest rdf:nil
131 Nb848d5af93634431ab51b9cdfbd62342 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Male
133 rdf:type schema:DefinedTerm
134 Nd3b755d751974086acd37b091e776a66 schema:name doi
135 schema:value 10.1007/bf00543493
136 rdf:type schema:PropertyValue
137 Nd52d9e3851f44c6c83ec73bf80f1c574 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Heart Rate
139 rdf:type schema:DefinedTerm
140 Nd558d92b125644cb8835729de7ac0748 rdf:first sg:person.01011650655.66
141 rdf:rest Nacdfdffc58c441e6a5852af8c2700274
142 Nd8d3ba159ebc48dc9a3a89ff1397bf92 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Posture
144 rdf:type schema:DefinedTerm
145 Ndda367c5e49048a5a32eabf5f35267e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Kinetics
147 rdf:type schema:DefinedTerm
148 Ne8a982d639a44563af3299a0a26225a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Antihypertensive Agents
150 rdf:type schema:DefinedTerm
151 Nf6b573fa3f4545fa89a31f51a6b7ec6a schema:affiliation grid-institutes:None
152 schema:familyName Sharp
153 schema:givenName P.
154 rdf:type schema:Person
155 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
156 schema:name Medical and Health Sciences
157 rdf:type schema:DefinedTerm
158 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
159 schema:name Clinical Sciences
160 rdf:type schema:DefinedTerm
161 sg:journal.1054337 schema:issn 0031-6970
162 1432-1041
163 schema:name European Journal of Clinical Pharmacology
164 schema:publisher Springer Nature
165 rdf:type schema:Periodical
166 sg:person.01011650655.66 schema:affiliation grid-institutes:None
167 schema:familyName Farrow
168 schema:givenName P. R.
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01011650655.66
170 rdf:type schema:Person
171 sg:person.0675422255.52 schema:affiliation grid-institutes:None
172 schema:familyName Ward
173 schema:givenName J. W.
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675422255.52
175 rdf:type schema:Person
176 sg:person.0743535455.00 schema:affiliation grid-institutes:None
177 schema:familyName McBurney
178 schema:givenName A.
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743535455.00
180 rdf:type schema:Person
181 sg:pub.10.1007/bf00562058 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036861154
182 https://doi.org/10.1007/bf00562058
183 rdf:type schema:CreativeWork
184 sg:pub.10.1007/bf01975139 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036141189
185 https://doi.org/10.1007/bf01975139
186 rdf:type schema:CreativeWork
187 sg:pub.10.1038/clpt.1980.234 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033747726
188 https://doi.org/10.1038/clpt.1980.234
189 rdf:type schema:CreativeWork
190 sg:pub.10.1038/clpt.1981.40 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048755408
191 https://doi.org/10.1038/clpt.1981.40
192 rdf:type schema:CreativeWork
193 grid-institutes:None schema:alternateName Department of Clinical Pharmacology Groby Road Hospital Leicester, England
194 schema:name Department of Clinical Pharmacology Groby Road Hospital Leicester, England
195 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...